These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
965 related articles for article (PubMed ID: 16910353)
1. [In situ carcinomas of the breast: clinical features and therapeutic strategies]. Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353 [TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Li CI; Malone KE; Saltzman BS; Daling JR Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564 [TBL] [Abstract][Full Text] [Related]
3. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up. Ringberg A; Andersson I; Aspegren K; Linell F Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650 [TBL] [Abstract][Full Text] [Related]
4. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ. Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343 [TBL] [Abstract][Full Text] [Related]
5. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
6. Is there a low-grade precursor pathway in breast cancer? King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
8. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study. Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086 [TBL] [Abstract][Full Text] [Related]
9. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment. Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402 [TBL] [Abstract][Full Text] [Related]
10. [The treatment of carcinoma in situ of the breast]. Raudrant D; Golfier F; Unger P Rev Fr Gynecol Obstet; 1990 Feb; 85(2):91-6. PubMed ID: 2157271 [TBL] [Abstract][Full Text] [Related]
11. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487 [TBL] [Abstract][Full Text] [Related]
12. Lobular carcinoma in situ of the breast. Goldschmidt RA; Victor TA Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318 [TBL] [Abstract][Full Text] [Related]
13. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Fisher ER; Costantino J; Fisher B; Palekar AS; Paik SM; Suarez CM; Wolmark N Cancer; 1996 Oct; 78(7):1403-16. PubMed ID: 8839545 [TBL] [Abstract][Full Text] [Related]
14. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Bradley SJ; Weaver DW; Bouwman DL Am Surg; 1990 Jul; 56(7):428-32. PubMed ID: 2164336 [TBL] [Abstract][Full Text] [Related]
15. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment. Andersen J; Blichert-Toft M; Dyreborg U Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823 [TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Sakorafas GH; Tsiotou AG Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968 [TBL] [Abstract][Full Text] [Related]
17. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Jolly S; Kestin LL; Goldstein NS; Vicini FA Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988 [TBL] [Abstract][Full Text] [Related]
18. 8. The dilemma of in situ carcinoma of the breast. Fentiman IS Int J Clin Pract; 2001 Dec; 55(10):680-3. PubMed ID: 11777293 [TBL] [Abstract][Full Text] [Related]
19. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]